Trial Type: Lymphoma (Pediatric)

Randomized Phase 3 Trial of Nivolumab
A Randomized Phase 3 Trial of Nivolumab (NSC# 748726) in Combination with Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell
Status: Open
Contact: Jennifer Welch, MD